Viatris Waves Goodbye To API Business

Closes Transaction To Divest API Unit To Matrix; Ongoing Supply Agreement In Place

Viatris has marked another milestone in its ongoing transformation by completing the previously-announced divestment of its active pharmaceutical ingredient business to Matrix Pharma Private Limited in India.

Divested word made of wood
Viatris has divested its API business • Source: Shutterstock

Viatris has completed another stage in the ongoing transformation of its business by closing the divestment of its active pharmaceutical ingredient business to India’s Matrix Pharma Private Limited.

Having in late 2022 earmarked the API business as a “non-core” asset that would be put up for sale –...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

Top 10 Drugs Q1 2026: New Sheriff In Town As Mounjaro Unseats Keytruda - Clone - Clone

Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains

Test

Wagner Adds Germany To Role As Stada Simplifies Structure

Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.

Type:DisclosureDevelopments | Publication:GB | Section:Business | Paywall:Free — Article containing all Composer content for testing (Do not update)

 
• By 

Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.

More from Business

uygukgigo

 
• By 

Test

Podcast test

 
• By